Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer
Clinical trial NCT06814158 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06814158
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-07-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.